Biochemics sec
WebGet free access to the complete judgment in Sec. & Exch. Comm'n v. BioChemics, Inc. on CaseMine. WebBiochemists work in industries like agriculture, medical research, biotechnology and nutritional research. Our students go on to positions in research and industry, as well as graduate study in biochemistry, …
Biochemics sec
Did you know?
WebLaw360, Boston (September 11, 2024, 6:30 PM EDT) -- The U.S. Securities and Exchange Commission and a Massachusetts federal judge appeared skeptical Tuesday of BioChemics Inc.'s claims that it... WebDefine biochemics. biochemics synonyms, biochemics pronunciation, biochemics translation, English dictionary definition of biochemics. ... The SEC previously obtained a $17 million judgment against BioChemics and a separate judgment against a promoter of BioChemics stock who wasn't registered as a broker.
WebAug 7, 2013 · BioChemics is a specialty pharmaceutical company focused on transdermal drug delivery systems, including medicated lotions. Masiz is BioChemics's president and chief executive officer. In May 2011 and September 2011, the SEC served document subpoenas on BioChemics requesting a broad range of documents regarding the … WebBioChemics paid $750,000 towards the judgment on Oct. 23, 2015. More than two years passed before its next deposit, an $87,500 payment to the SEC on Jan. 16, 2024, and …
WebMay 23, 2024 · Plaintiffs sought damages for what they claimed was AXIS's breach, under the relevant policy, of its duty to defend them in connection with an investigation conducted by the Securities and Exchange Commission against BioChemics and its officers. WebFeb 3, 2015 · § the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and § the SEC filed an enforcement action against Biochemics, Masiz, and two promoters...
WebMar 25, 2015 · The judgment entered on March 25, 2015, supplements the March 18, 2015 judgment, and requires BioChemics to disgorge $15,105,325 in ill-gotten gains plus …
WebAug 22, 2024 · According to the SEC complaint, BioChemics, Masiz and co-conspirators were accused of engaging in a fraudulent scheme to sell company securities to approximately 70 investors. The scheme, which ran from 2009 until the middle of 2012, netted at least $9 million. Investors caught up in the scheme resided in 19 different states. impulsbrytereWebThe treatment that could produce the money for BioChemics to pay down its SEC debt is already being prescribed by doctors associated with “leading medical institutions,” Schlichtmann said. In addition to the $17.2 million BioChemics owes the SEC, Florida-based private equity firm ADEC Private impuls bohdalecWebMar 4, 2024 · biochemistry, study of the chemical substances and processes that occur in plants, animals, and microorganisms and of the changes they undergo during … impuls benrathWebCompany profile page for BioChemics Inc including stock price, company news, press releases, executives, board members, and contact information lithium charge on periodic tableWebThe SEC claimed in a 2012 lawsuit that BioChemics and Masiz lied about the status of topical gels that would allow medicine to be absorbed through the skin. They allegedly falsely asserted the... impuls borgsdorfWebDec 14, 2012 · BioChemics of Danvers faces fraud charges By Beth Healy Globe Staff,December 14, 2012, 2:17 p.m. Federal securities regulators on Friday filed civil fraud charges against BioChemics Inc. of... impuls bern agWebthe SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December 2012 (after the expiration of the policy period). Biochemics notified AXIS of the January and March 2012 subpoenas. impuls biberach fitness